Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece

References

• LiuKKaffesAJIron deficiency anaemia: a review of diagnosis, investigation and managementEur J Gastroenterol Hepatol201224210911622157204
   PubMed Web of Science ®Google Scholar
• GoddardAFJamesMWMcIntyreASScottBBGuidelines for the management of iron deficiency anaemiaGut201160101309131621561874
   PubMed Web of Science ®Google Scholar
• GoonewardeneMShehataMAnaemia in pregnancyBest Pract Res Clin Obstet Gynaecol201226132422138002
   PubMed Web of Science ®Google Scholar
• KentAJBlackwellVJTravisSPWhat is the optimal treatment for anemia in inflammatory bowel disease?Curr Drug Deliv10212011 [Epub ahead of print.]
   Web of Science ®Google Scholar
• CavillIAuerbachMBailieGRIron and the anaemia of chronic disease: a review and strategic recommendationsCurr Med Res Opin200622473173716684434
   PubMed Web of Science ®Google Scholar
• PasrichaSRShould we screen for iron deficiency anaemia? A review of the evidence and recent recommendationsPathology201244213914722198251
   PubMed Web of Science ®Google Scholar
• LocatelliFPisoniRLCombeCAnaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS)Nephrol Dial Transplant200419112113214671047
   PubMed Web of Science ®Google Scholar
• de BenoistBMcLeanEEgliIWorldwide prevalence of anaemia 1993–2005WHO Global DatabaseGenevaWorld Health Organization2008 Available from: http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdfAccessed March, 8 2012
   Google Scholar
• MarantidouOLoukopoulouLZervouEFactors that motivate and hinder blood donation in GreeceTransfus Med200717644345018067648
   PubMed Web of Science ®Google Scholar
• KanavosPYfantopoulosJVandorosCPolitisCThe economics of blood: gift of life or a commodity?Int J Technol Assess Health Care200622333834316984062
   PubMed Web of Science ®Google Scholar
• CrichtonRDanielsonBGGeisserPIron Therapy with Special Emphasis on Intravenous Administration4th edLondon, UKInternational Medical Publishers2008
   Google Scholar
• KulniggSStoinovSSimanenkovVA novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trialAm J Gastroenterol200810351182119218371137
   PubMed Web of Science ®Google Scholar
• GordonSSHadleyPEVan WyckDBIron carboxymaltose, a new intravenous iron agent for iron deficiency anemia in heavy uterine bleedingObstet Gynecol2007109Suppl 4108S
   Web of Science ®Google Scholar
• QunibiWYMartinezCSmithMEfficacy and safety of IV ferric carboxymaltose (FCM) compared to oral iron in anemic patients with non-dialysis-dependent CKD45th Congress of the European Renal Association and the European Dialysis and Transplant AssociationStockholm2008
   Google Scholar
• SchaeferRMKhasabovNNTodorovNGThe efficacy and safety of intravenous ferric carboxymaltose compared to iron sucrose in haemodialysis patients with iron deficiency anaemiaPaper presented at: 45th Congress of the European Renal Association and the European Dialysis and Transplant AssociationStockholm2008
   Google Scholar
• BreymannCGligaFBejenariuCStrizhovaNComparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemiaInt J Gynaecol Obstet20081011677318234203
   PubMed Web of Science ®Google Scholar
• Van WyckDBMartensMGSeidMHBakerJBMangioneAIntravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trialObstet Gynecol20071102 Pt 126727817666600
   PubMed Web of Science ®Google Scholar
• SeidMHDermanRJBakerJBBanachWGoldbergCRogersRFerric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trialAm J Obstet Gynecol20081994435.e1e718928998
   PubMed Web of Science ®Google Scholar
• MooreRAGaskellHRosePAllanJMeta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial dataBMC Blood Disord201111421942989
   PubMedGoogle Scholar
• Ministry of Health and Social Solidarity [homepage on the Internet]2012 Available from: http://www.yyka.gov.grAccessed December 17, 2011
   Google Scholar
• Vifor FranceSAFerinject Summary of Product Characteristics2009 http://www.medicines.org.uk/EMC/medicine/24167/SPC/Ferinject+(ferric+carboxymaltoseAccessed September 15, 2011
   Google Scholar
• Vifor (International) IncVenofer (iron sucrose injection USP) http://www.medicines.org.uk/EMC/medicine/24168/SPC/Venofer+(iron+sucroseAccessed September 15, 2011
   Google Scholar
• Pharmacosmos A/SCosmofer Summary of Product Characteristics2010 http://www.medicines.org.uk/emc/medicine/14139/SPC/CosmosFer/Accessed September 15, 2011
   Google Scholar
• BhandariSA hospital-based cost minimization study of the potential financial impact on the UK health care system of introduction of iron isomaltoside 1000Ther Clin Risk Manag2011710311321479141
   PubMed Web of Science ®Google Scholar
• Lyseng-WilliamsonKAKeatingGMFerric carboxymaltose: a review of its use in iron-deficiency anaemiaDrugs200969673975619405553
   PubMed Web of Science ®Google Scholar
• Hellenic Statistical Authority Available from: http://www.statistics.grAccessed September 15, 2011
   Google Scholar
• AuerbachMWinchesterJWahabAA randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patientsAm J Kidney Dis199831181869428456
   PubMed Web of Science ®Google Scholar
• AuerbachMPappadakisJABahrainHAuerbachSABallardHDahlNVSafety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemiaAm J Hematol2011861086086221922526
   PubMed Web of Science ®Google Scholar
• ManiadakisNFragoulakisVPectasidesDFountzilasGXELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysisCurr Med Res Opin200925379780519215190
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical Excellence62008 available from: http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf Guide to the Methods of Technology AppraisalAccessed March 12, 2011
   Google Scholar
• WillanARStatistical analysis of cost-effectiveness data from randomized clinical trialsExpert Rev Pharmacoecon Outcomes Res20066333734620528526
   PubMedGoogle Scholar
• NissensonARWadeSGoodnoughTKnightKDuboisRWEconomic burden of anemia in an insured populationJ Manag Care Pharm200511756557416137214
   PubMedGoogle Scholar
• LymanGHBerndtERKallichJDThe economic burden of anemia in cancer patients receiving chemotherapyValue Health20058214915615804323
   PubMed Web of Science ®Google Scholar
• ErshlerWBChenKReyesEBDuboisREconomic burden of patients with anemia in selected diseasesValue Health20058662963816283863
   PubMed Web of Science ®Google Scholar
• BrockEBraunhoferPTroxlerJReal-life budget impact (BI) of parenteral iron treatment of iron deficiency in SwitzerlandISPOR 13th Annual European CongressNovember 9 2010Prague Poster No PSY12
   Google Scholar
• BagerPDahlerupJFThe health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspectiveJ Crohns Colitis20104442743021122539
   PubMed Web of Science ®Google Scholar
• Pugh-ClarkeKCooperLTurnerJFerminJAn evidence-based approach to anaemia management in predialysis chronic kidney diseaseJ Ren Care200935 Suppl 2293119891683
   PubMedGoogle Scholar
• Garcia-ErceJADiez-LoboAIMunozMA multicentre comparative study on the efficacy of intravenous ferric carboxymaltose and iron sucrose for correcting preoperative anaemia in patients undergoing major elective surgeryBr J Anaesth2011107347747821841061
   PubMed Web of Science ®Google Scholar